VC
GILD icon

V2 Capital’s Gilead Sciences GILD Stock Holding History

V2 Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.3M Buy
+13,224
New +$1.34M 0.54% 48

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

V2 Capital's GILD Position: Q1 2015 in Review

V2 Capital opened a new position in Gilead Sciences (GILD) in Q1 2015: 13,224 shares worth $1.3M. The stake represents 0.54% of the portfolio and ranks #48 among its holdings.

1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • V2 Capital held 13,224 shares of Gilead Sciences worth $1.3M as of Q1 2015.
  • Gilead Sciences was a new V2 Capital position in Q1 2015.
  • Gilead Sciences made up 0.54% of V2 Capital's portfolio in Q1 2015, its #48 holding.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.